Want to see AU:CSL full AI Analyst Report?
CSL (CSL) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Csl362 | Leukemia, Myeloid, Acute | Phase I | Completed | A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission | Jun 29, 2012 | ― |
| Ignextgen 10% | Idiopathic Thrombocytopenic Purpura (Itp) | Phase III | Completed | Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients | Aug 09, 2006 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Csl362 | Phase I | Leukemia, Myeloid, Acute | Completed | A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission | Jun 29, 2012 | ― |
| Ignextgen 10% | Phase III | Idiopathic Thrombocytopenic Purpura (Itp) | Completed | Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients | Aug 09, 2006 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does CSL Limited (AU:CSL) have in its pipeline
CSL AU:CSL is currently developing the following drugs: Csl362, Ignextgen 10%. These drug candidates are in various stages of clinical development as the company works toward FDA approval.